2rounds
—led
Enterprise software 1Proptech 1
Seed 1, Series A 1
Loading investors…
Loading investors…
Ranked by rounds participated in, from announcements in Jul 7, 2026 – Oct 4, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series B 2
Crystalys Therapeutics $130M Series BDraig Therapeutics $65M Series BNew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Circular Materials €11.8M UndisclosedProxima Fusion €411M GrowthNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
ORiS €5M Pre-SeedQuantumDiamonds €15M UndisclosedNew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Circular Materials €11.8M UndisclosedHyperion Robotics $7.4M GrowthNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Karoo Health $16.2M Series AHandspring $19M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Rege Nephro Co $10.6M Series CStarlight Engine $37.4M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Gritt $32.4M Seed+Series AHostie $12M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
ORiS €5M Pre-SeedDoctorsa €1M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
CuspAI $450M Series BTerraFirma $115M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
CuspAI $450M Series BState Affairs $70M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Final Boss Sour $4M StrategicFAVE $1M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
DeweyLearn $5M Series AAdvanCell $315M Series DNew companies 2 · Follow-on 0
Stages: Series C+ 2
Neko Health $700M Series CChai Discovery $400M Series CNew companies 2 · Follow-on 0
Stages: Series C+ 2
AdvanCell $315M Series DLeo Cancer Care $65M Series DNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Proaction $4.2M UndisclosedOllama $65M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Walden Robotics $300M UndisclosedHandspring $19M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Neko Health $700M Series CSpeakeasy $8.8M UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
AdvanCell $315M Series DDraig Therapeutics $65M Series BNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Velocity $38M Series ASherpa $2.2M Pre-SeedNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Hadrius $27M Seed+Series ACorner Health $32.5M Seed+Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
TerraFirma $115M Series AVenus Aerospace $91M Series BNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Nopan €7.2M UndisclosedSherpa $2.2M Pre-Seed“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.